Takeda Pharmaceutical Co., Ltd. (4502)

3,802.0 -31.0 (-0.81%)
Delayed Data JPY Disclaimer

Takeda Pharmaceutical Co., Ltd. Company Profile

Equity Type
Takeda Pharmaceutical Company Limited is a Japan-based company mainly engaged in the pharmaceutical business. The Company is engaged in the research, development, manufacture and sale of pharmaceutical products, General medical products, quasi drugs and healthcare products in Japan and overseas. The Company's research and development functions are concentrated in four areas of oncology (cancer), digestive system diseases, rare diseases and neurology (neuropsychiatric diseases), as well as two business units of plasma fractionation products and vaccines. The Company is engaged in the improvement of pipelines at research and development centers located mainly in Japan and the United States.
Contact Information
Tokyo,103-8668 Japan
81 3 3278 2111
81 3 3278 2000
Top Executives
Christophe Weber 56 2014 President, CEO & Representative Director
Andrew S. Plump 57 2015 President of Research & Development and Representative Director
Constantine Saroukos 51 2018 CFO & Representative Director
Masami Iijima 72 2021 Independent External Chair
Masato Iwasaki 64 2012 Representative Director
Shiro Kuniya 65 2013 Independent External Director
Koji Hatsukawa 71 2016 Head of Audit & Supervisory Committee
Steven S. Gillis 69 2019 Independent External Director
Jean-Luc Butel 66 2019 Independent External Director
Michel Orsinger 65 2016 Independent External Director
Yoshiaki Fujimori 71 2016 Member of Audit & Supervisory Committee
Olivier Bohuon 63 2019 Independent External Director
Emiko Higashi 64 2016 Member of Audit & Supervisory Committee Member
Ian T. Clark 62 2019 Independent External Director
Kimberly A. Reed 51 2022 Member of Audit & Supervisory Committee
John M. Maraganore 60 2022 Independent External Director
Clear All
Please try another search

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.